RECRUITING

Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Background: Infections in the lower respiratory tract (lungs) are the leading cause of death from infectious disease worldwide. This was true even before the COVID-19 pandemic. Respiratory viruses are still a major health threat. Many of these viruses infect people by penetrating the thin skin that lines the nose. These viruses can also spread easily to other people when they multiply in the tissues that line the nose. Researchers want to learn more about what these viruses do inside the nose, how they get from the nose to the lungs, and how they spread from person to person. Objective: To collect cell samples from inside the noses of healthy people. These cells will be stored for use in future research on respiratory diseases. Eligibility: Healthy volunteers aged 18 years and older. Design: Most participants will have 1 visit on 1 day. They will be asked questions. Those who have a runny nose, coughing, congestion, or fever will be asked to wait up to 21 days before participating. Participants will be given a slender swab with small bristles at the end. They will rub the inside of their nose with the swab. A clinic staff member will be present to help, if needed. Participants will provide their name, age, and sex. This information will be encoded so that only certain researchers will know the participants identities. Participants will not be contacted again....

Official Title

Establishment of a Biobank of Nasal Epithelium Samples From Healthy Volunteers

Quick Facts

Study Start:2023-11-01
Study Completion:2033-10-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06120244

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 99 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Aged \>=18 years.
  2. * Able to provide informed consent.
  3. * Willing to allow biological samples and data to be stored for future research.
  1. * History of respiratory symptoms including but not limited to runny nose, coughing, congestion, and/or fever within the past 14 days.
  2. * NIH and laboratory staff with direct involvement in the operation or maintenance of the repository are excluded from participation.
  3. * An individual who has any condition that, in the judgment of the investigator, may put them at undue risk or make them unsuitable for participation in the study will be excluded.

Contacts and Locations

Study Contact

Emmie de Wit, Ph.D.
CONTACT
(406) 375-7490
emmie.dewit@nih.gov

Principal Investigator

Emmie de Wit, Ph.D.
PRINCIPAL_INVESTIGATOR
National Institute of Allergy and Infectious Diseases (NIAID)

Study Locations (Sites)

Rocky Mountain Laboratories
Hamilton, Montana, 59840
United States

Collaborators and Investigators

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

  • Emmie de Wit, Ph.D., PRINCIPAL_INVESTIGATOR, National Institute of Allergy and Infectious Diseases (NIAID)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-11-01
Study Completion Date2033-10-31

Study Record Updates

Study Start Date2023-11-01
Study Completion Date2033-10-31

Terms related to this study

Keywords Provided by Researchers

  • Nasal Epithelium

Additional Relevant MeSH Terms

  • Healthy